Disturbances in the metabolism of TNF-α have been implicated in various metabolic disorders, such as obesity and insulin resistance (12), indicating that changes in the metabolism of TNF-α may affect the onset of T2DM, as well as the progression of the disease. Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.